Literature DB >> 15295100

A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.

Susan J Murch1, Paul Alan Cox, Sandra Anne Banack.   

Abstract

As root symbionts of cycad trees, cyanobacteria of the genus Nostoc produce beta-methylamino-l-alanine (BMAA), a neurotoxic nonprotein amino acid. The biomagnification of BMAA through the Guam ecosystem fits a classic triangle of increasing concentrations of toxic compounds up the food chain. However, because BMAA is polar and nonlipophilic, a mechanism for its biomagnification through increasing trophic levels has been unclear. We report that BMAA occurs not only as a free amino acid in the Guam ecosystem but also can be released from a bound form by acid hydrolysis. After first removing free amino acids from tissue samples of various trophic levels (cyanobacteria, root symbioses, cycad seeds, cycad flour, flying foxes eaten by the Chamorro people, and brain tissues of Chamorros who died from amyotrophic lateral sclerosis/Parkinsonism dementia complex), we then hydrolyzed the remaining fraction and found BMAA concentrations increased 10- to 240-fold. This bound form of BMAA may function as an endogenous neurotoxic reservoir, accumulating and being transported between trophic levels and subsequently being released during digestion and protein metabolism. Within brain tissues, the endogenous neurotoxic reservoir can slowly release free BMAA, thereby causing incipient and recurrent neurological damage over years or even decades, which may explain the observed long latency period for neurological disease onset among the Chamorro people. The presence of BMAA in brain tissues from Canadian patients who died of Alzheimer's disease suggests that exposure to cyanobacterial neurotoxins occurs outside of Guam.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295100      PMCID: PMC514403          DOI: 10.1073/pnas.0404926101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.

Authors:  Jason M B Wilson; Iraj Khabazian; David V Pow; Ulla K Craig; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Amyotrophic lateral sclerosis among Guamanians in California.

Authors:  J TORRES; L L IRIARTE; L T KURLAND
Journal:  Calif Med       Date:  1957-06

3.  2-Amino-3 (methylamino)-propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism.

Authors:  M W Duncan; I J Kopin; R M Garruto; L Lavine; S P Markey
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

Review 4.  Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration.

Authors:  J H Weiss; S L Sensi
Journal:  Trends Neurosci       Date:  2000-08       Impact factor: 13.837

5.  Complexes of zinc, copper, and nickel with the nonprotein amino acid L-alpha-amino-beta-methylaminopropionic acid: a naturally occurring neurotoxin.

Authors:  P B Nunn; P O'Brien; L D Pettit; S I Pyburn
Journal:  J Inorg Biochem       Date:  1989-10       Impact factor: 4.155

6.  Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.

Authors:  Sandra Anne Banack; Paul Alan Cox
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

7.  Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour.

Authors:  Jason M B Wilson; Iraj Khabazian; Margaret C Wong; Arash Seyedalikhani; Jaswinder S Bains; Bryce A Pasqualotto; David E Williams; Raymond J Andersen; Rebecca J Simpson; Richard Smith; Ulla-Kate Craig; Leonard T Kurland; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin.

Authors:  P S Spencer; P B Nunn; J Hugon; A C Ludolph; S M Ross; D N Roy; R C Robertson
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

9.  Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.

Authors:  Paul Alan Cox; Sandra Anne Banack; Susan J Murch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

10.  Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.

Authors:  I Khabazian; J S Bains; D E Williams; J Cheung; J M B Wilson; B A Pasqualotto; S L Pelech; R J Andersen; Y-T Wang; L Liu; A Nagai; S U Kim; U-K Craig; C A Shaw
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

View more
  90 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Assessing the Combined Toxicity of BMAA and Its Isomers 2,4-DAB and AEG In Vitro Using Human Neuroblastoma Cells.

Authors:  Brendan J Main; Kenneth J Rodgers
Journal:  Neurotox Res       Date:  2017-06-20       Impact factor: 3.911

Review 3.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

4.  Assessment of the non-protein amino acid BMAA in Mediterranean mussel Mytilus galloprovincialis after feeding with estuarine cyanobacteria.

Authors:  Mafalda S Baptista; Rita G W Vasconcelos; Paula C Ferreira; C Marisa R Almeida; Vitor M Vasconcelos
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-24       Impact factor: 4.223

5.  Roads, railways, and childhood cancers.

Authors:  E G Knox
Journal:  J Epidemiol Community Health       Date:  2006-02       Impact factor: 3.710

6.  Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

Authors:  Laura R Snyder; Reyniel Cruz-Aguado; Martin Sadilek; Douglas Galasko; Christopher A Shaw; Thomas J Montine
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

7.  Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.

Authors:  Sandra Anne Banack; Paul Alan Cox
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

Review 8.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

Review 9.  Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration.

Authors:  David Castanedo-Vazquez; Pilar Bosque-Varela; Arancha Sainz-Pelayo; Javier Riancho
Journal:  J Neurol       Date:  2018-05-29       Impact factor: 4.849

10.  Detection of the Cyanotoxins L-BMAA Uptake and Accumulation in Primary Neurons and Astrocytes.

Authors:  Vanessa X Tan; Claire Mazzocco; Bianca Varney; Dominique Bodet; Tristan A Guillemin; Alban Bessede; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-08-30       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.